Search research articles
Contact Us
Filters
Showing results (11-20 of 30) with videos related to
Page
of 3
Sort By:
Scandinavian Journal of Infectious Diseases
|
July 25, 2008
Role of hepatitis B virus, hepatitis D virus and other determinants on suppression of hepatitis C viraemia in HIV infected patients with chronic HCV infection: a longitudinal evaluation
Giorgio Antonucci, Francesco Vairo, Fabio Iacomi, et al.
Infectious Disease Reports
|
February 24, 2022
Vaccine-Induced Subacute Thyroiditis (De Quervain's) after mRNA Vaccine against SARS-CoV-2: A Case Report and Systematic Review
Giuseppe Pipitone, Lorenzo Vittorio Rindi, Nicola Petrosillo, et al.
Antiviral Therapy
|
May 12, 2009
Historical resistance profile helps to predict salvage failure
Mauro Zaccarelli, Patrizia Lorenzini, Francesca Ceccherini-Silberstein, et al.
AIDS Research and Human Retroviruses
|
October 27, 2007
gp41 sequence variability in HIV type 1 non-B subtypes infected patients undergoing enfuvirtide pressure
Roberta D'Arrigo, Massimo Ciccozzi, Caterina Gori, et al.
The American Journal of Gastroenterology
|
April 4, 2007
The effect of age on response to therapy with peginterferon alpha plus ribavirin in a cohort of patients with chronic HCV hepatitis including subjects older than 65 yr
Giorgio Antonucci, Maria Antonella Longo, Claudio Angeletti, et al.
Journal of the International AIDS Society
|
November 15, 2014
Simplification to co-formulated rilpivirine/emtricitabine/tenofovir in virologically suppressed patients: Data from a multicenter cohort
Carmela Pinnetti, Simona Di Giambenedetto, Franco Maggiolo, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
June 20, 2015
Switching to Coformulated Rilpivirine/Emtricitabine/Tenofovir in Virologically Suppressed Patients: Data From a Multicenter Cohort
Carmela Pinnetti, Simona Di Giambenedetto, Franco Maggiolo, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
January 17, 2004
Q151M-mediated multinucleoside resistance: prevalence, risk factors, and response to salvage therapy
Mauro Zaccarelli, Carlo Federico Perno, Federica Forbici, et al.
The Journal of Infectious Diseases
|
April 30, 2004
Mutations in HIV-1 reverse transcriptase potentially associated with hypersusceptibility to nonnucleoside reverse-transcriptase inhibitors: effect on response to efavirenz-based therapy in an urban observational cohort
Valerio Tozzi, Mauro Zaccarelli, Pasquale Narciso, et al.
Frontiers in Pharmacology
|
May 31, 2021
Synergy Between Vitamin D and Sex Hormones in Respiratory Functionality of Patients Affected by COVID-19
Daniela Peruzzu, Maria Teresa Pagano, Marina Pierdominici, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 30) with videos related to
Sort By:
Page
of 3
Scandinavian Journal of Infectious Diseases
|
July 25, 2008
Role of hepatitis B virus, hepatitis D virus and other determinants on suppression of hepatitis C viraemia in HIV infected patients with chronic HCV infection: a longitudinal evaluation
Giorgio Antonucci, Francesco Vairo, Fabio Iacomi, et al.
Infectious Disease Reports
|
February 24, 2022
Vaccine-Induced Subacute Thyroiditis (De Quervain's) after mRNA Vaccine against SARS-CoV-2: A Case Report and Systematic Review
Giuseppe Pipitone, Lorenzo Vittorio Rindi, Nicola Petrosillo, et al.
Antiviral Therapy
|
May 12, 2009
Historical resistance profile helps to predict salvage failure
Mauro Zaccarelli, Patrizia Lorenzini, Francesca Ceccherini-Silberstein, et al.
AIDS Research and Human Retroviruses
|
October 27, 2007
gp41 sequence variability in HIV type 1 non-B subtypes infected patients undergoing enfuvirtide pressure
Roberta D'Arrigo, Massimo Ciccozzi, Caterina Gori, et al.
The American Journal of Gastroenterology
|
April 4, 2007
The effect of age on response to therapy with peginterferon alpha plus ribavirin in a cohort of patients with chronic HCV hepatitis including subjects older than 65 yr
Giorgio Antonucci, Maria Antonella Longo, Claudio Angeletti, et al.
Journal of the International AIDS Society
|
November 15, 2014
Simplification to co-formulated rilpivirine/emtricitabine/tenofovir in virologically suppressed patients: Data from a multicenter cohort
Carmela Pinnetti, Simona Di Giambenedetto, Franco Maggiolo, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
June 20, 2015
Switching to Coformulated Rilpivirine/Emtricitabine/Tenofovir in Virologically Suppressed Patients: Data From a Multicenter Cohort
Carmela Pinnetti, Simona Di Giambenedetto, Franco Maggiolo, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
January 17, 2004
Q151M-mediated multinucleoside resistance: prevalence, risk factors, and response to salvage therapy
Mauro Zaccarelli, Carlo Federico Perno, Federica Forbici, et al.
The Journal of Infectious Diseases
|
April 30, 2004
Mutations in HIV-1 reverse transcriptase potentially associated with hypersusceptibility to nonnucleoside reverse-transcriptase inhibitors: effect on response to efavirenz-based therapy in an urban observational cohort
Valerio Tozzi, Mauro Zaccarelli, Pasquale Narciso, et al.
Frontiers in Pharmacology
|
May 31, 2021
Synergy Between Vitamin D and Sex Hormones in Respiratory Functionality of Patients Affected by COVID-19
Daniela Peruzzu, Maria Teresa Pagano, Marina Pierdominici, et al.
Page
of 3